Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Buys Pfizer Consumer Division For $16.6 Bil.

This article was originally published in The Pink Sheet Daily

Executive Summary

Johnson & Johnson CEO William Weldon says the deal will make the firm's portfolio "more balanced," with 40% devoted to pharmaceuticals, 35% to medical devices and 25% to consumer products.

You may also be interested in...



Pfizer & Wyeth: Is Mega Merger A Strategic Move Or Desperate Play?

A mega merger combining Pfizer and Wyeth would create a behemoth with combined sales of over $70 billion, build Pfizer's experience base in biotech, give Pfizer the substantial vaccine business it has been searching for and create billions in cost savings opportunities

Pfizer & Wyeth: Is Mega Merger A Strategic Move Or Desperate Play?

A mega merger combining Pfizer and Wyeth would create a behemoth with combined sales of over $70 billion, build Pfizer's experience base in biotech, give Pfizer the substantial vaccine business it has been searching for and create billions in cost savings opportunities

Pfizer & Wyeth: Is Mega Merger A Strategic Move Or Desperate Play?

Combination of Pfizer and Wyeth would create a drug powerhouse with combined sales of over $70 billion, strengthen Pfizer’s position in biotech and vaccines and create billions in cost savings opportunities.

Topics

UsernamePublicRestriction

Register

LL1135975

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel